Viewing nowCombinationDucarb Tablets 30/10 mg
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.

MFDS item code 201603069 · Approved 2016.05.30 · Insurance code 641906490
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with Pimasartan Potassium. This helps to effectively manage blood pressure when Pimasartan Potassium alone is not sufficient.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine. However, switching directly to this medicine may be considered if blood pressure is not controlled, as follows: ㆍ 30/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 30/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy or 30/5 mg. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/10 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or 60/5 mg. Patients taking fimasartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Older adults No initial dose adjustment is necessary in older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause serious harm to the fetus, particularly if taken during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, it should be discontinued immediately. This medication should not be administered to individuals with allergies to its components, pregnant or breastfeeding women, patients undergoing kidney dialysis, those with moderate to severe liver impairment, patients with biliary obstruction, individuals with certain hereditary lactose intolerance, patients with severe aortic stenosis, and those in shock. Caution should be exercised when administering to patients with reduced blood volume or impaired kidney function, those with renovascular hypertension, patients with aortic and mitral stenosis, primary aldosteronism, severe hypotension, elderly individuals, and patients with allergies to certain pigments. Upon taking this medication, side effects such as dizziness, headaches, facial swelling, urinary disorders, insomnia, and flushing may occur; consult a physician if any unusual symptoms appear. There may be a risk of hypotension or electrolyte imbalance, especially when used in conjunction with diuretics, so blood pressure and electrolyte levels should be monitored regularly. Patients with renal insufficiency or heart failure may be at risk for hyperkalemia and should have their serum potassium levels checked regularly. This medication may interact with other antihypertensive agents, diuretics, potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs, so inform healthcare providers of any concurrent medications. If pregnant or breastfeeding, the use of this medication may pose a risk to the fetus and newborn, so a consultation with a physician is essential before deciding to use it. Safety in children has not been established; therefore, it is advised not to use it in individuals under 18 years of age. Elderly patients or those with liver impairment may require dosage adjustments or should use this medication with caution, and it is deemed unsafe for individuals with severely impaired liver function. In cases of overdose, symptoms may include hypotension, palpitations, bradycardia, and vasodilation; contact a medical institution immediately for appropriate treatment. This medication should be kept out of reach of children and not transferred to another container to maintain its quality. Drowsiness or dizziness may occur while taking this medication; caution is advised during driving or operating hazardous machinery.
Not everyone experiences these, and they can vary from person to person.
This medication may be light-sensitive, so it should be stored in a container that blocks light. Additionally, it is vital to store the medication at room temperature, between 1°C and 30°C, to maintain its effectiveness.
Green apple-shaped film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 150mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Fimasartan Potassium Trihydrate Granules 75mg · Amlodipine Besylate 13.88mg
Tablet · Prescription medication · Combination
Boryung Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.